Ovarian Enzyme Identified as Potential Target for PMOS
Researchers found an enzyme that drives androgen excess, offering a new potential focus for future condition management.
Updated on Oct. 16, 2026 in Nutrition
Researchers have identified that an overactive enzyme in ovarian cells contributes to polyendocrine metabolic ovarian syndrome (PMOS). This mechanism highlights a potential new therapeutic target for managing the condition.
Why it matters
Understanding this metabolic and epigenetic pathway is a first step toward developing future treatments for PMOS. The findings explain how molecular dysregulation leads to the hallmark androgen excess seen in the syndrome.
In a preclinical study using mouse models, researchers demonstrated that overexpression of the enzyme nicotinamide N-methyltransferase contributes to the progression of polyendocrine metabolic ovarian syndrome. These findings establish a preliminary link between epigenetic markers and androgen production.
The details
The enzyme nicotinamide N-methyltransferase functions by reducing histone H3 lysine 27 trimethylation within ovarian granulosa cells. This reduction increases the expression of retinoic acid receptor beta, which subsequently amplifies ovarian androgen synthesis. This creates a self-sustaining feedforward loop where the resulting androgen excess further suppresses histone methylation.
Health Landscape
This study advances the field of reproductive endocrinology by connecting metabolic enzyme activity to epigenetic regulation in ovarian function. It builds on the broader efforts to map the complex molecular landscape of metabolic-endocrine syndromes.
This research is currently in early preclinical stages and does not change clinical care or treatment protocols today. Any concerns regarding symptoms of ovarian or endocrine syndromes remain a topic to discuss with your physician.
The takeaway
This research highlights a new molecular pathway involving enzymes and gene expression that may influence androgen levels in PMOS. Readers should continue to monitor their health with a specialist and rely on established medical guidelines rather than emerging preclinical data.
Further reading
For more information on the intersection of metabolism and hormones, visit our Nutrition section.
Source note: This article includes information reported by Nature.
